Breaking News Instant updates and real-time market news.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, NKE

Nike

$71.13

-1.39 (-1.92%)

07:23
11/21/18
11/21
07:23
11/21/18
07:23

Foot Locker price target raised to $64 from $58 at Wells Fargo

Wells Fargo analyst Tom Nikic raised his price target for Foot Locker (FL) to $64 from $58 and reiterated an Outperform rating on the shares. The analyst believes Foot Locker's turnaround story continues to pick up steam, as he thinks the Q3 print alleviated many of the concerns that have weighed on the shares this year. Nikic continues to view Foot Locker as a "very compelling turnaround story," driven by improving product flows, strong relationships with their key vendors such as Nike (NKE), a capable management team that has shown an ability to quickly adapt to changing market conditions, and a stock that is still fairly inexpensive.

FL

Foot Locker

$46.10

-2.69 (-5.51%)

NKE

Nike

$71.13

-1.39 (-1.92%)

  • 20

    Dec

FL Foot Locker
$46.10

-2.69 (-5.51%)

11/21/18
LEHM
11/21/18
NO CHANGE
Target $70
LEHM
Overweight
Barclays remains bullish on shares of Foot Locker
In a post-earnings research note titled "Good Things Come to Those Who Wait," Barclays analyst Matthew McClintock says he remains bullish on shares of Foot Locker. The company is "clearly on the path to acceleration" that management has referred to all year, which indicates 2019 "could prove to be a return to normalcy," McClintock tells investors. He increased his estimates and keeps an Overweight rating on Foot Locker with a $70 price target.
11/21/18
PIPR
11/21/18
NO CHANGE
Target $51
PIPR
Neutral
Foot Locker price target raised to $51 from $42 at Piper Jaffray
Piper Jaffray analyst Erinn Murphy raised her price target for Foot Locker to $51 following the company's better than expected Q3 results. The analyst says that while her long-term view is unchanged, she commends Foot Locker's execution. The analyst increased her estimates but keeps a Neutral rating on the shares.
11/14/18
LEHM
11/14/18
NO CHANGE
Target $70
LEHM
Overweight
Foot Locker well positioned to meet this quarter's guidance, says Barclays
Barclays analyst Matthew McClintock believes Foot Locker (FL) is well positioned to meet guidance this quarter with further acceleration into Q4 and beyond. The analyst, who acknowledges that comp expectations are likely for flat to slightly negative, says Nike's (NKE) recently reported wholesale revenue growth of 5.2% is a "strong indication of an inflection" in Foot Locker's business. The analyst is estimating a 2.6%, above the 1.8% consensus, increase in comp store sales for Foot Locker and earnings per share of 94c, or a 3c beat. He keeps an Overweight rating on the shares with a $70 price target.
11/12/18
COWN
11/12/18
NO CHANGE
Target $56
COWN
Market Perform
Foot Locker price target raised to $56 from $46 at Cowen
Cowen analyst John Kernan raised his price target on Foot Locker to $56 from $46 and also raised his estimates following channel checks which show significantly improved full-price selling trends in North America. Kernan said concerns over long-term growth and margin structure keep him at Market Perform on Foot Locker shares.
NKE Nike
$71.13

-1.39 (-1.92%)

10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Flex downgraded to Hold from Buy at Argus
Argus analyst Jim Kelleher downgraded Flex (FLEX) to Hold after its "disappointing" Q2 results and "weak" Q3 guidance revealed last week. The analyst also cites the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound", as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. Kelleher adds that the loss of Nike compounds lost business from other high-profile clients, including toymaker Lego as well as numerous mobile device makers.
10/27/18
GSCO
10/27/18
DOWNGRADE
GSCO
Neutral
Flex downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Mark Delaney downgraded Flex (FLEX) to Neutral following the company's Q2 results and announcement of a CEO change and wind down of its footwear manufacturing operations with Nike (NKE) in Mexico. While Flex's current valuation is "very inexpensive," the CEO transition and "consumer disengagement" could provide an overhang for several quarters, Delaney tells investors in a research note. Flex closed Friday down 35%, or $3.82, to $7.09.
10/22/18
OPCO
10/22/18
NO CHANGE
OPCO
Outperform
Nike well positioned to weather potential tariffs, says Oppenheimer
Oppenheimer analyst Brian Nagel argues that while the dynamic surrounding potential, incremental tariffs on Chinese-manufactured items imported to the U.S. is fluid, Nike is quite well insulated to this threat. Per his math, footwear and apparel manufactured in China and sold in the U.S. represent just 10%-15% of total production in these categories for Nike, and the company already operates manufacturing facilities elsewhere in Asia and could further shift production out of China, over time, if necessary. Further, Nagel points out that management indicates that given the complexity of the overall Nike manufacturing and sourcing operations, the company has many levers to pull in order to help offset impacts of potential incremental import costs. Athletic footwear and apparel manufactured in China are already subject to duties at a mid-teens rate, while the company is enjoying significant pricing power with consumers, he adds. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$228.37

-92.1 (-28.74%)

, AAPL

Apple

$194.85

6.71 (3.57%)

12:12
03/21/19
03/21
12:12
03/21/19
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rising this…

BIIB

Biogen

$228.37

-92.1 (-28.74%)

AAPL

Apple

$194.85

6.71 (3.57%)

MU

Micron

$43.54

3.46 (8.63%)

F

Ford

$8.63

0.12 (1.41%)

AMZN

Amazon.com

$1,804.86

7.5 (0.42%)

SNAP

Snap

$10.87

-0.07 (-0.64%)

LEVI

Levi Strauss

$22.67

(0.00%)

SRNE

Sorrento Therapeutics

$4.32

0.83 (23.78%)

DRI

Darden

$116.20

7.58 (6.98%)

CSIQ

Canadian Solar

$19.76

-3.78 (-16.06%)

GES

Guess

$19.02

-3.08 (-13.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 04

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

  • 21

    Mar

VREX

Varex Imaging

$34.09

0.13 (0.38%)

12:10
03/21/19
03/21
12:10
03/21/19
12:10
Conference/Events
Varex Imaging management to meet with Northland »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

CTL

CenturyLink

$11.98

0.08 (0.67%)

12:05
03/21/19
03/21
12:05
03/21/19
12:05
Options
CenturyLink call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
03/21/19
03/21
12:05
03/21/19
12:05
General news
Treasury announced a $113 B batch of coupon auctions »

Treasury announced a $113…

X

U.S. Steel

$20.46

0.68 (3.44%)

12:05
03/21/19
03/21
12:05
03/21/19
12:05
Hot Stocks
U.S. Steel announces enhanced benefits for its non-represented employees »

United States Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVH

Evolent Health

$13.81

0.655 (4.98%)

12:04
03/21/19
03/21
12:04
03/21/19
12:04
Recommendations
Evolent Health analyst commentary  »

Recent indications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBDO

Banco Bradesco

$10.43

(0.00%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Banco Bradesco falls -7.2% »

Banco Bradesco is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$15.27

-1.72 (-10.12%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Intelsat falls -10.1% »

Intelsat is down -10.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$18.96

-3.14 (-14.21%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Guess falls -14.0% »

Guess is down -14.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$3.53

0.245 (7.46%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Crescent Point Energy rises 8.0% »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$25.50

2.595 (11.33%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Conagra Brands rises 11.4% »

Conagra Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CHAP

Chaparral Energy

$5.95

0.64 (12.05%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Chaparral Energy rises 12.2% »

Chaparral Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZBY

Commerzbank

$0.00

(0.00%)

, DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

11:59
03/21/19
03/21
11:59
03/21/19
11:59
Periodicals
Deutsche Bank board discussed Commerzbank merger for 3 hours, Reuters says »

Deutsche Bank's (DB)…

CRZBY

Commerzbank

$0.00

(0.00%)

DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$228.26

-92.21 (-28.77%)

11:53
03/21/19
03/21
11:53
03/21/19
11:53
Downgrade
Biogen rating change at Cantor Fitzgerald »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

JAZZ

Jazz Pharmaceuticals

$136.47

2.74 (2.05%)

11:50
03/21/19
03/21
11:50
03/21/19
11:50
Recommendations
Jazz Pharmaceuticals analyst commentary at Wells Fargo »

Jazz appoval expected but…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
03/21/19
03/21
11:50
03/21/19
11:50
General news
Treasury's $95 B 4- and 8-week bill sales were mixed »

Treasury's $95 B 4-…

EVH

Evolent Health

$13.74

0.585 (4.45%)

11:47
03/21/19
03/21
11:47
03/21/19
11:47
Recommendations
Evolent Health analyst commentary at KeyBanc »

Kentucky Medicaid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$103.54

1.2 (1.17%)

11:45
03/21/19
03/21
11:45
03/21/19
11:45
Options
PayPal call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$37.75

-0.12 (-0.32%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
Conference/Events
Boston Scientific management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

ORHOF

Origin House

$0.00

(0.00%)

, ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
On The Fly
Rising High: An exclusive talk with cannabis brands company Origin House »

In this edition of…

ORHOF

Origin House

$0.00

(0.00%)

ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

APHA

Aphria

$9.98

-0.15 (-1.48%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$20.67

-0.59 (-2.78%)

CGC

Canopy Growth

$45.90

-0.9 (-1.92%)

TLRY

Tilray

$69.93

-0.7 (-0.99%)

IGC

India Globalization Capital

$2.02

0.12 (6.32%)

KNHBF

ICC International Cannabis

$0.00

(0.00%)

ORTFD

Biome Grow

$0.00

(0.00%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

OGRMF

Organigram

$0.00

(0.00%)

KSHB

KushCo Holdings

$0.00

(0.00%)

MMNFF

MedMen

$0.00

(0.00%)

ELLXF

Elixinol Global

$0.00

(0.00%)

PLNHF

Planet 13 Holdings

$0.00

(0.00%)

KHRNF

Khiron Life Sciences

$0.00

(0.00%)

LHSIF

Liberty Health Sciences

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

FB

Facebook

$164.56

-0.91 (-0.55%)

11:37
03/21/19
03/21
11:37
03/21/19
11:37
Hot Stocks
Facebook says issues fixed after finding user passwords readable by employees »

Facebook's VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

11:36
03/21/19
03/21
11:36
03/21/19
11:36
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:36
03/21/19
03/21
11:36
03/21/19
11:36
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:35
03/21/19
03/21
11:35
03/21/19
11:35
General news
U.S. equities have ramped higher »

U.S. equities have ramped…

SRC

Spirit Realty

$37.60

0.54 (1.46%)

11:31
03/21/19
03/21
11:31
03/21/19
11:31
Conference/Events
Spirit Realty management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.